Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Face Perception
NCT02238379Phase 1Completed
- Sponsor
- Yale University
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray, sponsored by Yale University. Primary endpoints: Amplitude Social at 30 months and Amplitude Non-Social at 30 months. Started Sep 2014; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT02238379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02238379.